EUVIMEDEUVIMED entdecken
Crossref

Enhanced Anticancer Efficacy of Novel Asiminatide A Isolated from Asimina triloba in Triple-Negative Breast Cancer

Zijun Li, Kandasamy Saravanakumar iD, Lulu Yao, Yunyeong Kim, Jungyu Jo, Sang Yoon Choi, Guijae Yoo, Phil Jun Lee, Soeun Kim, Namki Cho iD

Biomacromolecules · 2026

DOI: 10.1021/acs.biomac.5c01953 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomacromolecules, 2026. Verfasst von Zijun Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Pharmaceutical Sciences, College of Pharmacy, Chonnam National University, Gwangju 61186, Republic of Korea. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Peptides, Cyclic, Antineoplastic Agents. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Korea Food Research Institute, National Research Foundation of Korea, Ministry of Climate, Energy, and Environment of the Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsPeptides, CyclicAntineoplastic AgentsHumansFemaleAnimalsNanoparticlesCell Line, TumorMiceChitosanDrug LiberationFolic AcidMice, NudeXenograft Model Antitumor Assays

Substanzen

Peptides, CyclicAntineoplastic AgentsChitosanFolic Acid

Autor:innen und Institutionen

  • Research Institute of Pharmaceutical Sciences, College of Pharmacy, Chonnam National University, Gwangju 61186, Republic of Korea.
  • Elicure, 45 Jamiro 6 beon-gil, Buk-gu, Gwangju 61226, Republic of Korea.
  • Korea Food Research Institute, 245, Nongsaengmyeong-ro, Iseo-myeon, Wanju-Gun, Jeollabuk-do 55365, Republic of Korea.

ORCID-Profile: Kandasamy Saravanakumar, Namki Cho

Förderung

  • Korea Food Research Institute
  • National Research Foundation of Korea
  • Ministry of Climate, Energy, and Environment of the Republic of Korea

Zitieren

APA

Li, Z., Saravanakumar, K., Yao, L., Kim, Y., Jo, J., Choi, S. Y., Yoo, G., Lee, P. J., Kim, S., & Cho, N. (2026). Enhanced Anticancer Efficacy of Novel Asiminatide A Isolated from Asimina triloba in Triple-Negative Breast Cancer. Biomacromolecules. https://doi.org/10.1021/acs.biomac.5c01953

Vancouver

Li Z, Saravanakumar K, Yao L, Kim Y, Jo J, Choi SY, et al. Enhanced Anticancer Efficacy of Novel Asiminatide A Isolated from Asimina triloba in Triple-Negative Breast Cancer. Biomacromolecules. 2026. doi:10.1021/acs.biomac.5c01953

BibTeX
@article{Li2026,
  author = {Li, Zijun and Saravanakumar, Kandasamy and Yao, Lulu and Kim, Yunyeong and Jo, Jungyu and Choi, Sang Yoon and Yoo, Guijae and Lee, Phil Jun and Kim, Soeun and Cho, Namki},
  title = {Enhanced Anticancer Efficacy of Novel Asiminatide A Isolated from Asimina triloba in Triple-Negative Breast Cancer},
  journal = {Biomacromolecules},
  year = {2026},
  doi = {10.1021/acs.biomac.5c01953}
}
Kostenlos starten →